RNA 시퀀싱 서비스 시장 : 업계 동향과 세계 예측(-2035년) - 시퀀싱 방법별, 응용 분야별, 최종사용자 업계별, 지역별

RNA SEQUENCING SERVICE MARKET: OVERVIEW

As per Roots Analysis, the RNA sequencing service market is USD is projected to grow from USD 3.3 billion in the current year and is expected to reach USD 7.5 billion by 2035, representing a CAGR of 8.4% during the forecast period.

RNA Sequencing Service Market

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Sequencing Method

• Next Generation Sequencing Method
• Other Methods

Application Area

• Diagnostic
• Research

End User Industry

• Academic and Research
• Clinics and Hospital
• Pharmaceutical Industry
• Others

Geographical Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and North Africa

RNA SEQUENCING SERVICES MARKET: GROWTH AND TRENDS

RNA sequencing was initially presented by Fredrick Sanger in 1977, utilizing the chain termination technique, also referred to as the Sanger sequencing method or first-generation sequencing method. It is a rapid technique that allows for the profiling of the complete spectrum of RNA produced by the cell, with enhanced coverage and resolution. Although, the Sanger sequencing technique is more expensive than alternative methods and has limited detection capability, which diminishes its scalability. With time, the RNA sequencing service market has undergone numerous technological advancements, and various RNA sequencing methods are currently employed for differential gene and allele-specific expression, small RNA profiling, characterization of alternative splicing patterns, and systems biology.

Among different sequencing techniques, next generation sequencing (NGS) launched by Lynx Therapeutics in 2000, has become a favored option throughout the industry. It is a parallel genome sequencing technology with high throughput that allows for whole genome and whole exome sequencing. It allows for a decrease in total cost and processing duration. Even with numerous technological progressions in RNA sequencing, there are several persistent issues, such as challenges in sequencing large genes, a scarcity of human resources, and insufficient tools for data manipulation and analysis. Moreover, the development and maintenance of facilities based on next generation sequencing demand significant investment. To address these challenges and achieve a high-quality result, industry players view the outsourcing of RNA sequencing as a more favorable choice compared to other options.

At present, over 70 firms provide services associated with RNA sequencing. Several of these firms are new ventures that were founded in the last ten years. Moreover, various stakeholders are involved in developing their proprietary technologies to address the issues associated with amplification and duplication rates during sequencing. Additionally, more than 340 patents concerning RNA sequencing have been recently issued or filed, showcasing the innovation. Further, in recent years, the National Institutes of Health have awarded grants worth USD 486 million to bolster the ongoing R&D initiatives in the RNA sequencing service sector. Fueled by the increasing interest from diverse stakeholders and the broad applicability of this technique, we expect that the RNA sequencing services sector will experience significant market growth in the forecast period.

RNA SEQUENCING SERVICE MARKET: KEY INSIGHTS

The report delves into the current state of the RNA sequencing service market and identifies potential growth opportunities within industry. Some key findings from the report include:

1. Close to 75 players, across the globe, claim to offer services for RNA sequencing; a relatively larger proportion of these players are start ups / small companies, established in the US post 2010.

2. Majority of the service providers (38%) offer services for sequencing of small RNA and mRNA; Illumina is the most widely employed platform for sequencing different RNA samples.

3. In pursuit of building a competitive edge, stakeholders are striving to enhance their service portfolio and upgrade their facilities with advanced sequencing platforms.

4. More than 340 patents related to RNA sequencing have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field.

5. Over the past few years, grants worth USD 1,034 million have been awarded to various organizations in order to support the ongoing research and innovation efforts.

6. RNA sequencing for transcriptome profiling has become a widely used technique in life sciences industry, leading to an increase in opportunities within this domain.

7. Sequencing platforms with less turnaround time are likely to have high profitability index and offer more profit potential to the companies offering RNA sequencing services.

8. The RNA sequencing services market is expected to grow at a rate of 8.4%, till 2035; the market opportunity is likely to be well distributed across different methods, applications, end-users and geographies.

RNA SEQUENCING SERVICE MARKET: MARKET SEGMENTS

Next Generation Sequencing Service Market is Likely to Capture the Majority of the RNA Sequencing Service Market

In terms of type of sequencing method, the next generation sequencing service market is segmented across next generation sequencing methods and other methods. Currently, majority of the market share is captured by next generation sequencing methods constituting nearly 95% of the market and the trend is likely to remain the same during the forecast period.

Majority of the RNA Sequencing Service Market Share is Captured by Hospitals

In terms of type of end user, the RNA sequencing services market is segmented across hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes and others. Currently, majority of the market share is captured by hospitals constituting around 45% of the market share. The segment is likely to grow at a notable CAGR during the period.

North America is Likely to Dominate the RNA Sequencing Service Market

In terms of type of geographical regions, the RNA sequencing services market is segmented across North America, Europe, Asia-Pacific, Latin America and MENA. Currently, majority (37%) of the market share is captured by North America and the trend is unlikely to change in the future.

Example Players in the RNA Sequencing Services Market

• Admera Health
• Biogazelle (acquired by CellCarta)
• CD Genomics
• Creative Biogene
• IGA Technology
• LC Sciences
• Lexogen
• Novogene
• Otogenetics
• Yaazh Xenomic

RNA SEQUENCING SERVICES MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the RNA sequencing services market, focusing on key market segments, including [A] type of sequencing method, [B] application area, [C] end user industry, and [D] key geographical regions.
• Market Landscape: A detailed analysis of the overall market landscape of RNA sequencing service providers based on several relevant parameters, such as [A] year of establishment, [A] company size, [B] location of headquarters, [C] type of RNA sequencing service(s), type of platform, [D] turnaround time, [E] type of sample and [F] volume of sample.
• Company Competitiveness Analysis: A comprehensive competitive analysis of RNA sequencing service providers, examining factors, such as [A] company strength and [B] service portfolio strength.
• Company Profiles: In-depth profiles of prominent players offering providing services for RNA sequencing, headquartered in North America, Europe and Asia-Pacific focusing on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
• Grants Analysis: A detailed analysis of grants awarded to various research institutes for projects related to RNA sequencing, based on several relevant parameters, such as [A] year of grant awarded, [B] amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] purpose of grant, [G] activity code, [H] study section, [I] type of organization, [J] emerging focus areas, [K] popular NIH departments, [L] popular recipient organizations (in terms of number of grants and amount awarded), [M] prominent program officers and [N] location of recipient organizations.
• Patent Analysis: An insightful analysis of patents filed / granted for RNA sequencing, since 2018, taking into consideration various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] geographical location, [E] CPC symbols, [F] emerging focus areas, [G] type of applicant, [H] leading players and [I] individual assignees (in terms of number of patents granted / filed in the given time period).
• Porter's Five Forces Analysis: A qualitative analysis of the five competitive forces, including [A] threats of new entrants, [B] bargaining power of customers, [C] bargaining power of RNA sequencing service providers, [D] threats of substitute services and [E] rivalry among existing competitors under an insightful Porter's Five Forces framework.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4 Key Questions Answered
• 1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. An Overview of RNA Sequencing
  • 3.2.1. Key Steps Involved in RNA Sequencing
  • 3.2.2. Types of RNA Sequencing
    • 3.2.2.1. Single End Sequencing
    • 3.2.2.2. Paired End Sequencing
  • 3.2.3. Methods of RNA Sequencing
    • 3.2.3.1. First Generation Sequencing
    • 3.2.3.2. Next Generation Sequencing
    • 3.2.3.3. Third Generation Sequencing
  • 3.2.4. Applications of RNA Sequencing
  • 3.2.5. Advantages of RNA Sequencing
  • 3.2.6. Limitations of RNA Sequencing
  • 3.2.7. RNA Sequencing Platforms
    • 3.2.7.1. Illumina Sequencing Platforms
    • 3.2.7.2. Pac Bio Sequencing Platforms
    • 3.2.7.3. Nanopore Sequencing Platforms
• 3.3. Concluding Remarks

4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW

• 4.1. Chapter Overview
  • 4.1.1. RNA Sequencing Service Providers
  • 4.1.2. Analysis by Year of Establishment
  • 4.1.3. Analysis by Company Size
  • 4.1.4. Analysis by Location of Headquarters
  • 4.1.5. Analysis by Company Size and Region of Headquarters
  • 4.1.6. Analysis by Type of RNA Sequencing Service(s)
  • 4.1.7. Analysis by Type of Platform
  • 4.1.8. Analysis by Turnaround Time
  • 4.1.9. Analysis by Type of Sample
  • 4.1.10. Analysis by Amount of Sample

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions and Key Parameters
• 5.3. Scope and Methodology
• 5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
• 5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
• 5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Admera Health
  • 6.2.1. Company Overview
  • 6.2.2. RNA Sequencing Service Portfolio
  • 6.2.3. Recent Developments and Future Outlook
• 6.3. Biogazelle (acquired by CellCarta)
  • 6.3.1. Company Overview
  • 6.3.2. RNA Sequencing Service Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. CD Genomics
  • 6.4.1. Company Overview
  • 6.4.2. RNA Sequencing Service Portfolio
  • 6.4.3. Recent Developments and Future Outlook
• 6.5. Creative Biogene
  • 6.5.1. Company Overview
  • 6.5.2. RNA Sequencing Service Portfolio
  • 6.5.3. Recent Developments and Future Outlook
• 6.6. IGA Technology
  • 6.6.1. Company Overview
  • 6.6.2. RNA Sequencing Service Portfolio
  • 6.6.3. Recent Developments and Future Outlook
• 6.7. LC Sciences
  • 6.7.1. Company Overview
  • 6.7.2. RNA Sequencing Service Portfolio
  • 6.7.3. Recent Developments and Future Outlook
• 6.8. Lexogen
  • 6.8.1. Company Overview
  • 6.8.2. RNA Sequencing Service Portfolio
  • 6.8.3. Recent Developments and Future Outlook
• 6.9. Novogene
  • 6.9.1. Company Overview
  • 6.9.2. RNA Sequencing Service Portfolio
  • 6.9.3. Recent Developments and Future Outlook
• 6.10. Otogenetics
  • 6.10.1. Company Overview
  • 6.10.2. RNA Sequencing Service Portfolio
  • 6.10.3. Recent Developments and Future Outlook
• 6.11. Yaazh Xenomic
  • 6.11.1. Company Overview
  • 6.11.2. RNA Sequencing Service Portfolio
  • 6.11.3. Recent Developments and Future Outlook

7. ACADEMIC GRANT ANALYSIS

• 7.1. Chapter Overview
• 7.2. Scope and Methodology
• 7.3. Analysis by Year of Grant Award
  • 7.3.1. Analysis by Amount Awarded
  • 7.3.2. Analysis by Administering Institute Centre
  • 7.3.3. Analysis by Support Period
  • 7.3.4. Analysis by Administering Institute Centre and Support Period
  • 7.3.5. Analysis by Type of Grant Application
  • 7.3.6. Analysis by Purpose of Grant
  • 7.3.7. Analysis by Purpose of Grant and Amount Awarded
  • 7.3.8. Analysis by Activity Code
  • 7.3.9. Analysis by Study Section Involved
  • 7.3.10. Analysis by Type of Organization
  • 7.3.11. Word Cloud: Emerging Focus Areas
  • 7.3.12. Most Popular Departments: Analysis by Number of Grants
  • 7.3.13. Prominent Program Officers: Analysis by Number of Grants
  • 7.3.14. Popular Recipient Organizations: Analysis by Number of Grants
  • 7.3.15. Popular Recipient Organizations: Analysis by Amount Awarded
  • 7.3.16. Analysis of Recipient Organizations located in the US

8. PATENT ANALYSIS

• 8.1. Chapter Overview
• 8.2. Scope and Methodology
• 8.3. RNA Sequencing: Patent Analysis
  • 8.3.1. Analysis by Publication Year
  • 8.3.2. Analysis by Application Year
  • 8.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
  • 8.3.4. Analysis by Geography
  • 8.3.5. Analysis by CPC Symbols
  • 8.3.6. Analysis by Focus Area
  • 8.3.7. Analysis by Type of Applicant
  • 8.3.8. Leading Players: Analysis by Number of Patents
  • 8.3.9. Leading Individual Assignees: Analysis by Number of Patents
• 8.4. RNA Sequencing: Patent Benchmarking Analysis
  • 8.4.1. Analysis by Patent Characteristics
• 8.5. RNA sequencing: Patent Valuation Analysis
• 8.6. Leading Patents: Analysis by Number of Citations

9. PORTER'S FIVE FORCES ANALYSIS

• 9.1. Chapter Overview
• 9.2. Methodology and Assumptions
• 9.3. Key Parameters
  • 9.3.1. Threats of New Entrants
  • 9.3.2. Power of Customers
  • 9.3.3. Power of RNA Sequencing Service Providers
  • 9.3.4. Threats of Substitute Services
  • 9.3.5. Rivalry Among Existing Competitors
• 9.4. Concluding Remarks

10. CASE STUDY: NGS LIBRARY PREPARATION KITS

• 10.1. Chapter Overview
• 10.2. NGS Library Preparation Kits: Overall Market Landscape
  • 10.2.1. Analysis by Type of Platform
  • 10.2.2. Analysis by Amount of Sample
  • 10.2.3. Analysis by Turnaround Time
  • 10.2.4. Analysis by Storage Temperature
  • 10.2.5. Analysis by Type of Sequencing
  • 10.2.6. Analysis by Kit Components
  • 10.2.7. Analysis by Type of Sample
• 10.3. NGS Library Preparation Kits: Developer Landscape
  • 10.3.1. Analysis by Year of Establishment
  • 10.3.2. Analysis by Company Size
  • 10.3.3. Analysis by Region of Headquarters

11. INVESTMENT POTENTIAL ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Profit Potential of Commonly used RNA Sequencing Platforms
  • 11.2.1. iSeq: Likely Profit Potential
  • 11.2.2. MiSeq: Likely Profit Potential
  • 11.2.3. NextSeq 550 Series: Likely Profit Potential
  • 11.2.4. NextSeq 1000: Likely Profit Potential
  • 11.2.5. NextSeq 1000: Likely Profit Potential
  • 11.2.6. Sequel: Likely Profit Potential
  • 11.2.7. Sequel II: Likely Profit Potential
  • 11.2.8. Sequel IIe: Likely Profit Potential
• 11.4. Payback Evaluation Matrix
• 11.3. Conclusion

12. MARKET SIZING AND OPPORTUNITY ANALYSIS

• 12.1. Chapter Overview
• 12.2. Forecast Methodology and Key Assumptions
• 12.3. Global RNA Sequencing Services Market, Till 2035
  • 12.3.1. RNA Sequencing Services Market, Till 2035: Distribution by Type of Sequencing Method
    • 12.3.1.1. RNA Sequencing Services Market for Next Generation Sequencing Methods, Till 2035
    • 12.3.1.2. RNA Sequencing Services Market for Other Methods, Till 2035
  • 12.3.2. RNA Sequencing Services Market, Till 2035: Distribution by Type of Application Area
    • 12.3.2.1. RNA Sequencing Services Market for Research Purposes, Till 2035
    • 12.3.2.2. RNA Sequencing Services Market for Diagnostic Purposes, Till 2035
  • 12.3.3. RNA Sequencing Services Market, Till 2035: Distribution by Type of End User Industry
    • 12.3.3.1. RNA Sequencing Services Market for Academic and Research Industry, Till 2035
    • 12.3.3.2. RNA Sequencing Services Market for Clinics and Hospitals, Till 2035
    • 12.3.3.3. RNA Sequencing Services Market for Pharmaceutical Industry, Till 2035
    • 12.3.3.4. RNA Sequencing Services Market for Other Users, Till 2035
  • 12.3.4. RNA Sequencing Services Market, Till 2035: Distribution by Key Geographical Regions
    • 12.3.4.1. RNA Sequencing Services Market in North America, Till 2035
    • 12.3.4.2. RNA Sequencing Services Market in Europe, Till 2035
    • 12.3.4.3. RNA Sequencing Services Market in Asia-Pacific, Till 2035
    • 12.3.4.4. RNA Sequencing Services Market in Latin America, Till 2035
    • 12.3.4.5. RNA Sequencing Services Market in Middle East and North Africa, Till 2035

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS